A Real-World Study Comparing Effectiveness of Disease-Modifying Therapies (DMTs) for the Management of Multiple Sclerosis in Routine Clinical Practice using US Claims Data.
Phase of Trial: Phase IV
Latest Information Update: 13 Jul 2017
At a glance
- Drugs Dimethyl fumarate (Primary) ; Fingolimod; Glatiramer acetate; Interferon beta; Teriflunomide
- Indications Multiple sclerosis
- Focus Therapeutic Use
- 13 Jul 2017 New trial record
- 01 Jun 2017 Results published in the Neurology and Therapy Journal.